Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor-Reference-Cited by-同舟云学术

Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor

Published:2018-08-16 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Subhash Vinod Vijay,Yeo Mei Shi,Wang Lingzhi,Tan Shi Hui,Wong Foong Ying,Thuya Win Lwin,Tan Woei Loon,Peethala Praveen C.,Soe Mu Yar,Tan David S. P.,Padmanabhan Nisha,Baloglu Erkan,Shacham Sharon,Tan Patrick,Koeffler H. Phillip,Yong Wei Peng

Funder

MOH | National Medical Research Council (NMRC)

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-30686-1.pdf

Reference40 articles.

1. Crochiere, M. L. et al. A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds. Oncotarget 7, 1863–1877, https://doi.org/10.18632/oncotarget.6495 (2016).

2. Turner, J. G. & Sullivan, D. M. CRM1-mediated nuclear export of proteins and drug resistance in cancer. Curr Med Chem 15, 2648–2655 (2008).

3. Chang, Y. J. et al. In Cell Microbiol Vol. 8 1740–1752 (2006).

4. Xu, D., Farmer, A. & Chook, Y. M. Recognition of nuclear targeting signals by Karyopherin-beta proteins. Curr Opin Struct Biol 20, 782–790, https://doi.org/10.1016/j.sbi.2010.09.008 (2010).

5. Hill, R., Cautain, B., de Pedro, N. & Link, W. Targeting nucleocytoplasmic transport in cancer therapy. Oncotarget 5, 11–28, https://doi.org/10.18632/oncotarget.1457 (2014).

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel—and Not So Novel—Inhibitors of the Multifunctional CRM1 Protein;Oncology Reviews;2024-08-05

2. XPO1 serves as a prognostic marker involving AKT/MAPK/TGFBR1 pathway in OSCC;Cancer Medicine;2024-08

3. Construction and validation of prognostic signatures related to mitochondria and macrophage polarization in gastric cancer;Frontiers in Oncology;2024-07-26

4. Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition;Leukemia;2024-07-13

5. Beyond oncology: Selinexor’s journey into anti-inflammatory treatment and long-term management;Frontiers in Immunology;2024-05-10